Almost everything we know about how to diagnose and treat cancer today was learned through the participation of people just like you. You can make a difference for future cancer patients by taking part in a clinical trial.
Your provider will discuss whether a clinical trial is available to you. Enrolling is your choice. You may choose to take part or not and are free to leave at any time.
See our open cancer clinical trials below. For more information, including how to enroll, please call 609-677-7735.
To learn more about clinical trials, visit the National Cancer Institute site.
Active Clinical Trials
Brain Cancer | Breast Cancer | Gastrointestinal Cancer | Head & Neck Cancer | Lung Cancer | Multiple Disease Sites | Prostate Cancer
Brain Cancer
CCTG-CE.7
Category
Brain Cancer
Full Name
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5-15 Brain Metastases
Brief Description
A Phase III Trial of Stereotactic Radiosurgery Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) plus Memantine for 5 – 15 brain metastases
Sponsor
NCI Sponsored
ClinicalTrials.gov ID NCT03550391
View on Clinical Trials.gov
|
|
|
Breast Cancer
NRG-CC011
Category
Breast Cancer
Full Name
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors: A Multi-Center Randomized Double-Blinded Controlled Trial
Brief Description
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Sponsor
NRG Oncology
ClinicalTrials.gov ID NCT05896189
View on Clinical Trials.gov
|
S1703
Category
Breast Cancer
Full Name
Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Brief Description
A Randomized Trial Comparing Overall Survival of Patients Monitored with Serum Tumor Marker Directed Disease Monitoring (STMDDM) versus Usual Care.
Sponsor
SWOG Sponsored
ClinicalTrials.gov ID NCT03723928
View on Clinical Trials.gov
|
NRG-CC015
Category
Breast Cancer
Full Name
Harnessing E-mindfulness Approaches for Living After Breast Cancer-HEAL-ABC
Brief Description
A prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App).
Sponsor
NRG Oncology
ClinicalTrials.gov ID NCT06748222
View on Clinical Trials.gov
|
Gastrointestinal Cancer
NRG-GI008
Category
Gastrointestinal Cancer
Full Name
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Brief Description
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.
Sponsor
NRG Oncology Sponsored
ClinicalTrials.gov ID NCT05174169
View on Clinical Trials.gov
|
|
|
Head & Neck Cancer
EA3161
Category
Head & Neck Cancer
Full Name
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
Brief Description
A Phase II/III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate-Risk HPV Positive Oropharyngeal Cancer
Sponsor
NCI Sponsored
ClinicalTrials.gov ID NCT03811015
View on Clinical Trials.gov
|
|
|
Lung Cancer
NRG-LU008
Category
Lung Cancer
Full Name
Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer
Brief Description
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Sponsor
NRG Sponsored
ClinicalTrials.gov ID NCT05624996
View on Clinical Trials.gov
|
|
|
Multiple Disease Sites
Research Patient Registry
Category
Multiple Disease Sites
Full Name
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Brief Description
A research registry of the de-identified treatment and follow-up data of patients receiving stereotactic radiosurgery (SRS)/stereotactic body radiation therapy (SBRT), including CyberKnife (CK)
Sponsor
The Radiosurgery Society Sponsored
ClinicalTrials.gov ID NCT01885299
View on Clinical Trials.gov
|
|
|
Prostate Cancer
A032304
Category
Prostate Cancer
Full Name
Radioligand Efficacy Comparison by Initial PSA-Response Outcome in Metastatic CRPC With Lutetium 177Lu PSMA RLT (RECIPROCAL).
Brief Description
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial.
Sponsor
Alliance Sponsored
ClinicalTrials.gov ID NCT07200830
View on Clinical Trials.gov
|
|
|